Abstract:Introduction: Progranulin (PGRN) is a secreted glycoprotein, the expression of which is linked to several neurodegenerative diseases. Although its specific function is still unclear, several studies have linked it with lysosomal functions and immune system regulation. Here, we have explored the role of PGRN in peripheral and central immune system homeostasis by investigating the consequences of PGRN deficiency on adaptive and innate immune cell populations. Methods: First, we used gene co-expression network analysis of published data to test the hypothesis that Grn has a critical role in regulating the activation status of immune cell populations in both central and peripheral compartments. To investigate the extent to which PGRN-deficiency resulted in immune dysregulation, we performed deep immunophenotyping by flow cytometry of 19-24-month old male and female Grn-deficient mice (PGRN KO) and littermate Grn-sufficient controls (WT). Results: Male PGRN KO mice exhibited a lower abundance of microglial cells with higher MHC-II expression, increased CD44 expression on monocytes in the brain, and more CNS-associated CD8+ T cells compared to WT mice. Furthermore, we observed an increase in CD44 on CD8+ T cells in the peripheral blood. Female PGRN KO mice also had fewer microglia compared to WT mice, and we also observed reduced expression of MHC-II on brain monocytes. Additionally, we found an increase in Ly-6Chigh monocyte frequency and decreased CD44 expression on CD8+ and CD4+ T cells in PGRN KO female blood. Given that Gpnmb, which encodes for the lysosomal protein Glycoprotein non-metastatic melanoma protein B, has been reported to be upregulated in PGRN KO mice, we investigated changes in GPNMB protein expression associated with PGRN deficits and found that GPNMB is modulated in myeloid cells in a sex-specific manner. Discussion: Our data suggest that PGRN and GPNMB jointly regulate the peripheral and the central immune system in a sex-specific manner; thus, understanding their associated mechanisms could pave the way for developing new neuroprotective strategies to modulate central and peripheral inflammation to lower risk for neurodegenerative diseases and possibly delay or halt progression.

Circulating PGRN is significantly associated with systemic insulin sensitivity and autophagic activity in metabolic syndrome.

Progranulin Induces Adipose Insulin Resistance and Autophagic Imbalance Via TNFR1 in Mice.

Pgrn Induces Impaired Insulin Sensitivity And Defective Autophagy In Hepatic Insulin Resistance

PGRN Exerts Inflammatory Effects Via SIRT1-NF-κB in Adipose Insulin Resistance.

Administration of Progranulin (PGRN) Triggers ER Stress and Impairs Insulin Sensitivity Via PERK-eIF2α-dependent Manner

Circulating PGRN Levels Are Increased but Not Associated with Insulin Sensitivity or Β-Cell Function in Chinese Obese Children.

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

Serum Levels of Progranulin Are Closely Associated with Microvascular Complication in Type 2 Diabetes

PGRN Acts As a Novel Regulator of Mitochondrial Homeostasis by Facilitating Mitophagy and Mitochondrial Biogenesis to Prevent Podocyte Injury in Diabetic Nephropathy

Progranulin Controls Sepsis Via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.

Progranulin Facilitates Conversion and Function of Regulatory T Cells under Inflammatory Conditions

Increased Expression of PGRN Protein in Follicular Fluid and Mrna in Granulosa Cells in Overweight Patients with Polycystic Ovary Syndrome.

Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions

Circulating progranulin in human infants: relation to prenatal growth and early postnatal nutrition

Progranulin loss results in sex-dependent dysregulation of the peripheral and central immune system

Progranulin (PGRN) as a regulator of inflammation and a critical factor in the immunopathogenesis of cardiovascular diseases

Progranulin is Highly Expressed in Patients with Chronic Periodontitis and Protects Against Experimental Periodontitis in Rats

PGRN Suppresses Inflammation and Promotes Autophagy in Keratinocytes Through the Wnt/β-Catenin Signaling Pathway

Progranulin inhibits autophagy to facilitate intracellular colonization of Helicobacter pylori through the PGRN/mTOR/DCN axis in gastric epithelial cells

Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion